# PathMap Report Trace Context: #00000127
Hypothesis: Neuroinflammatory astrocyte subtypes in the mouse brain
Author: Joshua Dungan (PathMap.org)
License: 'THE GLOBAL HUMANITARIAN PROPRIETARY LICENSE (VERSION 1.0.1)' https://pathmap.org/license.pdf
Full provenance JSON trace: https://pathmap.org/download.php/?id=127
==================================================

SYSTEM NOTE: The eight-digit ID numbers (e.g., ID 12345678) used in citations below are PubMed ID numbers and can be loaded via https://pubmed.ncbi.nlm.nih.gov/{ID}/ for verification.

==================================================

## Primary Synthesis & Clinical Bottom-Line
Neuroinflammatory astrocyte activation is a complex, state-dependent phenomenon. Rather than functioning as static subtypes, astrocytes exhibit dynamic transcriptomic and proteomic remodeling in response to diverse pathological stimuli (e.g., ischemia, amyloid-beta, pro-inflammatory cytokines). Evidence supports a "continuum model" of astrocyte states, where functional programming is influenced by cell-type-specific regulators, local metabolic demands, and bidirectional crosstalk with microglia.

## Plausibility Verdicts
- Evaluation 1: Astrocyte subtypes in the mouse brain are best described as dynamic functional states along a continuum, rather than fixed, rigid categories.
- Evaluation 2: Mouse brain astrocytes display transcriptional diversity, with specific reactive subtypes orchestrating neuroinflammation and BBB integrity.
- Evaluation 3: Astrocyte subtypes are not binary; they are highly dynamic, state-dependent functional cells influenced by specific signaling hubs like STING, FGF13, and Tweak.

## Novel & Overlooked Insights
- Astrocyte activation is not exclusively a proliferative process; in models such as peripheral nerve injury, spinal astrocytes respond primarily through remodeling rather than cell division.
- The astrocyte-microglia network, rather than individual cell activation, serves as the critical functional unit for containing lesions and restoring homeostasis.
- Perisynaptic astrocyte processes represent unique "hotspots" for local protein synthesis that may bypass global cellular transcriptional states.
- The expression of specific proteins, such as MINK1 and PLEKHB1, provides a spatial coordinate system for astrocyte functional identity across different brain regions.
- Lipid metabolism (e.g., long-chain fatty acids) and mitochondrial function are primary drivers of the neurotoxic astrocyte phenotype in ischemic injury.
- The "neurotoxic" vs. "neuroprotective" paradigm for astrocyte activation is being replaced by the understanding that states are highly state-dependent and cannot be explained by simplified paradigms.
- Mechanical signaling via Piezo1, regulated by microglia-derived cytokines, links physical tissue alterations to the inflammatory profile of astrocytes.
- Transcriptional Heterogeneity:** Astrocytes exist in at least five distinct subpopulations following traumatic injury, with Osmr+ variants exhibiting specific neurotoxic and protective metabolic signatures.
- Mechanical Sensing:** Endothelial Piezo1 sensors translate mechanical stress into astrocytic apoptosis via cAMP-Epac1 microvesicular signaling.
- Gut-Brain Signaling:** Chronic enteric gliosis in Parkinson's disease-model mice (A53T) precedes CNS inflammation, driven by LRRK2 up-regulation.
- Barrier Regulation:** Astrocytes serve as primary regulators of the blood-brain barrier, often utilizing the cGAS-STING pathway to govern tight junction stability.
- Regenerative Potential:** "Direct in situ astrocyte-to-neuron reprogramming offers a compelling regenerative alternative by leveraging the abundant endogenous glial reservoir," though this is hindered by existing epigenetic memory.
- Stress Resilience:** Structural depolymerization of AQP4 orthogonal array particles in A25Q mutant mice confers resilience to chronic stress by dampening glial-mediated neuroinflammation.
- Developmental Plasticity:** Adolescent intermittent ethanol exposure disrupts the physical and functional coupling of astrocytes to synapses, a deficit that persists into adulthood.
- Metabolic Rewiring:** Astrocytes undergo significant metabolic transitions during reprogramming, shifting from glycolysis to oxidative phosphorylation to support nascent neuronal survival.
- Astrocyte reactivity is not merely a binary 'A1/A2' state; modern transcriptomic analysis reveals finer gradations of cellular activation.
- The TRPC6-STING pathway represents a specific, druggable hub for stabilizing the blood-brain barrier via astrocytes during ischemia.
- Peripheral inflammation, as seen in atopic dermatitis or respiratory infection, directly reshapes cortical astrocytic transcriptional landscapes.
- Senescence markers in astrocytes and neurons represent a distinct, aging-associated inflammatory pathway mediated by cGAS-STING.
- Dietary interventions, such as a nut-enriched diet, can actively suppress pro-inflammatory astrocyte markers in AD mouse models.
- Clusterin (CLU) secretion from astrocytes, triggered by STING activation, is a primary driver of oligodendrocyte apoptosis in MS.
- FGF13 acts as a critical molecular switch that prevents astrocytic apoptosis and associated depression-like behavioral deficits.
- The Tweak/Fn14 and Stat1 signaling loop constitutes a positive feedback mechanism specifically fueling astrocytic activation in TLE.

## Extracted Custom Discoveries
### Suggested Experiments
- Perform spatial transcriptomics on astrocyte perisynaptic processes in multi-hit models of neurodegeneration to map the influence of local vs. global signals.
- Test the therapeutic efficacy of temporal-specific inhibition of LMP2 in late-stage chronic neuroinflammatory models.
- Spatial transcriptomic profiling of Osmr+ astrocytes in chronic versus acute neurodegeneration models.
- Chemogenetic activation/silencing of identified reactive astrocyte subpopulations to measure synaptic recovery.
- Perform single-cell spatial transcriptomics on astrocyte populations in the Tweak/Snhg3-knockout mouse TLE model.
- Assess the effect of astrocyte-specific FGF13 supplementation on hippocampal synaptic density in aging models.
- Use patch-clamp electrophysiology on astrocytes sorted by specific disease-associated markers to determine functional shifts in glutamate homeostasis.

### Suggested Studies
- Longitudinal analysis of astrocyte proteomic signatures in aging populations vs. disease-associated models using spatial proteomics.
- Comparative analysis of human vs. mouse astrocyte reactivity markers to bridge translational gaps in current CNS research.
- Cross-species transcriptomic meta-analysis to determine if mouse astrocyte states correlate with human pathological lesions.
- Longitudinal imaging of astrocyte-neuron crosstalk using sensors for calcium and neurotransmitter uptake post-injury.
- A comparative longitudinal transcriptomic study of astrocytic subtypes across various stages of Alzheimer's disease progression.
- Meta-analysis of astrocyte-specific transcriptomic datasets to reconcile nomenclature differences between injury-reactive models.

### Swansons Literature Based Discovery Candidates
- S100B inhibition in astrocyte perisynaptic processes may mitigate pre-symptomatic synaptic loss in non-KLEFS1 neurodegenerative conditions.
- EHMT1 deficiency in astrocytes increases S100B levels leading to network hyperactivity (Source: 42378039).
- Early translational dysregulation in PAPs in AD precedes plaque deposition (Source: 42425228).
- S100B regulation within astrocyte sub-compartments via JAK-STAT3 signaling.
- Since S100B is a marker for inflammatory reactive states and JAK-STAT3 is a known driver of Serpina3n expression in PAPs, it is plausible that S100B accumulation is a downstream target of this early translational pathway in broader neurodegenerative models.
- Discovered Hypothesis (A to C): Inhibition of AQP4 orthogonal array particle stabilization via site-specific mutations could mitigate astrocyte-driven neurotoxicity in traumatic brain injury.
Literature A (Origin): AQP4-A25Q mutations prevent OAP assembly and improve stress resilience (42595228).
Literature C (Target): Osmr+ reactive astrocytes and neurotoxicity in TBI (42603599).
The Intersecting Bridge B: Reactive gliosis and neuroinflammatory pathway suppression (GFAP/cGAS-STING).
Biological Rationale: Reducing AQP4-dependent OAP formation likely limits the astrocytic stress response that precipitates the pathological reactive states observed in TBI, thereby preventing the transition to the Osmr+ neurotoxic phenotype.
- Snhg3-mediated astrocytic activation is a key metabolic driver of synaptic vulnerability in aging-related neurodegenerative niches.
- Tweak/Snhg3 positive feedback loop in astrocytes drives TLE (ID 42456384).
- Astrocytic energy metabolism genes are critical for neuron protection in AD pathology (ID 42403013).
- Snhg3/Tweak-driven metabolic reprogramming.
- The Tweak/Snhg3 loop alters gene transcription; if this loop is active in AD, it likely impairs the metabolic homeostasis required for healthy OL-astrocyte-neuron communication.

### Contradictions Between Evidences
- Conflicting roles of zafirlukast: ID 42557520 reports zafirlukast exacerbates seizure activity despite reducing neurodegeneration markers, while other studies (e.g., 42458512, 42398271) suggest inflammatory modulation is consistently protective, indicating target-specific complexities in epileptogenesis.
- Evidence regarding astrocyte roles varies from 'protective/homeostatic' to 'deleterious/pro-inflammatory' based on the insult type and temporal window (42589548), indicating that astrocyte phenotype is highly conditional.
- There is a tension in the literature between viewing astrocytes as a binary A1 (toxic)/A2 (protective) paradigm versus the emerging evidence from single-cell transcriptomics which suggests a vast, fluid landscape of reactive states depending on the specific inflammatory trigger and disease stage.

### Repurposed Solutions
- The use of HFn-ApoE130-149 nanocarriers to target the LRP1-NF-κB signaling axis represents a repurposed solution for modulating astrocyte reactivity in various neuroinflammatory disorders, not just NMOSD, by crossing the BBB to restore astrocytic homeostasis.
- Intranasal NPY and intranasal insulin are identified as potent therapeutic strategies for modulating astrocyte reactive states and preserving the neurovascular unit after injury (42575454, 42600992).
- Repurpose Tweak/Snhg3 inhibitors developed for epilepsy (42456384) to mitigate glial reactivity and cognitive decline in AD models, as common pathways involving inflammatory signaling are implicated in both.

## Evaluation Scoring Reference
All analyzed perspectives utilize a standardized 1-7 scoring framework:
- Alignment Score (1-7): How well does the evaluated claim factually align with the provided evidence set?
  [1 = Evidence proves claim strictly false, 2 = Evidence indicates the claim is impossible, 3 = Implausible, 4 = Neutral/Unrelated, 5 = Plausible, 6 = Evidence indicates inevitable, 7 = Evidence proves claim strictly true]
- Consilience Score (1-7): How consilient (in agreement) is the evidence set regarding this claim?
  [1 = Highly Conflicting/Disputed, 4 = Mixed, 7 = Unanimous Agreement]
- Confidence Score (1-7): Implied confidence of the research based on study design and depth.
  [1 = In Vitro/Animal/Preprint, 4 = Observational/Moderate, 7 = Meta-analysis/RCT]

## Evaluated Perspectives & Findings
### Perspective R1: Claim [Run1 Eval1 Synthesis] evaluated against Evidence [N/A]
- Alignment Score: 5/7
- Consilience Score: 6/7
- Directional Logic: High Score = SUPPORTS Original Claim
Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although "Zero Hallucinated Moneyshot Quotes" is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.

###[CLAIM EVALUATED AND ANSWER TO USER]
The claim evaluated is that neuroinflammatory astrocyte subtypes in the mouse brain are well-defined entities that mediate pathology in neurodegenerative disorders. The evidence set indicates that while astrocyte reactivity is a hallmark of neuroinflammatory responses in various mouse models, the categorization into distinct, stable subtypes remains an area of active investigation. The provided literature suggests that astrocytic responses exist along a functional continuum rather than being confined to simple binary "neurotoxic" or "neuroprotective" states.

### [ABSTRACT & REWRITTEN CLAIM]
Neuroinflammatory astrocyte activation is a complex, state-dependent phenomenon. Rather than functioning as static subtypes, astrocytes exhibit dynamic transcriptomic and proteomic remodeling in response to diverse pathological stimuli (e.g., ischemia, amyloid-beta, pro-inflammatory cytokines). Evidence supports a "continuum model" of astrocyte states, where functional programming is influenced by cell-type-specific regulators, local metabolic demands, and bidirectional crosstalk with microglia.

### [INTRODUCTION & JUSTIFICATION]
Astrocyte activation, often termed astrogliosis, is an essential mechanism in the central nervous system (CNS) response to injury and neurodegeneration. In mouse models, this reactivity is characterized by the upregulation of intermediate filament proteins such as GFAP. Recent high-resolution molecular profiling has challenged the existence of binary astrocyte phenotypes. Instead, research indicates that reactive astrocytes undergo heterogeneous remodeling, influenced by specific upstream signaling pathways and metabolic shifts. For instance, the immunoproteasome subunit LMP2 has been identified as a critical regulator that modulates the balance between inflammatory and reparative gene programs in astrocytes following ischemic injury. Similarly, local translation of specific mRNAs in perisynaptic astrocyte processes provides an early, compartment-specific layer of control that contributes to synaptic dysfunction in Alzheimer’s disease. Crucially, the functional outcome of astrocytic activation is highly context-dependent, often necessitating coordinated interactions with other glial populations, such as microglia, through signaling axes like the CX3CR1 or the LRP1-NF-κB pathway. Consequently, current research is moving toward a framework where reactive states are viewed as dynamic "motifs" shaped by spatial and temporal microenvironmental factors.

### [DISCUSSION: NOVEL & OVERLOOKED]
*   Astrocyte activation is not exclusively a proliferative process; in models such as peripheral nerve injury, spinal astrocytes respond primarily through remodeling rather than cell division.
*   The astrocyte-microglia network, rather than individual cell activation, serves as the critical functional unit for containing lesions and restoring homeostasis.
*   Perisynaptic astrocyte processes represent unique "hotspots" for local protein synthesis that may bypass global cellular transcriptional states.
*   The expression of specific proteins, such as MINK1 and PLEKHB1, provides a spatial coordinate system for astrocyte functional identity across different brain regions.
*   Lipid metabolism (e.g., long-chain fatty acids) and mitochondrial function are primary drivers of the neurotoxic astrocyte phenotype in ischemic injury.
*   The "neurotoxic" vs. "neuroprotective" paradigm for astrocyte activation is being replaced by the understanding that states are highly state-dependent and cannot be explained by simplified paradigms.
*   Mechanical signaling via Piezo1, regulated by microglia-derived cytokines, links physical tissue alterations to the inflammatory profile of astrocytes.

### [EVIDENCE, METHODOLOGY & CITATIONS]
1. ID: 42504987 - Application: LMP2 regulates the transition of astrocyte states. - "LMP2 coordinately modulates inflammatory and reparative signaling networks by promoting nuclear factor kappa-B (NF-κB)-dependent inflammatory activation while constraining transforming growth factor-β1(TGF-β1)/SMAD family member 3 (Smad3)-associated reparative responses"
2. ID: 42547642 - Application: Notes the limitations of binary classification. - "exosome function is highly state-dependent and cannot be fully explained by simplified pro-inflammatory microglia anti-inflammatory microglia (M1/M2) or A1/A2 paradigms"
3. ID: 42467524 - Application: Spatial heterogeneity of astrocytes. - "MINK1 and PLEKHB1 showed preferential expression in hippocampal and cortical astrocytes, respectively, highlighting their potential as region-specific astrocyte markers."
4. ID: 42362040 - Application: LPI effects on astrocytic activation in AD. - "Exogenous LPI treatment reduced cerebral Aβ deposition, improved performance in learning and memory behavioral tasks, reduced pathological microglial aggregation, inhibited astrocyte proliferation, and ameliorated hippocampal oxidative stress."
5. ID: 42539240 - Application: Metabolic profiling of astrocytes. - "Integrated epigenomic, proteomic, and metabolomic profiling of cortical astrocytes isolated 28 days after injury revealed a pronounced metabolic restriction in wild type astrocytes"
6. ID: 42552048 - Application: Metabolic support in AD. - "While the brain relies on lactate as a prominent energy substrate, astrocytic metabolic defects lead to impaired neuronal energy homeostasis, thereby promoting neurodegeneration."
7. ID: 42511849 - Application: Tay-Sachs astrocyte model features. - "The resulting cell line recapitulates key pathological features, including lysosomal accumulation, increased neutral lipid content, reduced mitochondrial mass, and elevated reactive oxygen species production."
8. ID: 42462474 - Application: circSLC8A1 localization. - "circSLC8A1 was significantly upregulated in the hippocampus of TLE mice and predominantly localized in astrocytes."
9. ID: 42560948 - Application: P2X7 mechanism in heat stress. - "Mild hyperthermia upregulated P2X7 expression in astrocytes and induced a substantial calcium influx, leading to activation of the Calcineurin-NFAT pathway."
10. ID: 42523300 - Application: AQP4 in vascular disease. - "Aquaporin 4 (AQP4) water channels are polarized to astrocytic endfeet at blood vessel interfaces, and lose polarity in vascular diseases"
11. ID: 42449389 - Application: Nanotherapeutic impact on astrocyte phenotype. - "The treatment induced a spatial and phenotypic restructuring of the astrocytic response, notably reducing excessive astrocyte accumulation around lesions while encouraging a proliferative and reparative phenotype."
12. ID: 42378039 - Application: S100B in EHMT1 models. - "EHMT1+/- astrocytes displayed elevated levels of S100B, a neuroinflammatory marker contributing to neuronal network hyperactivity."
13. ID: 42369041 - Application: Cx50 mediated crosstalk. - "Cx50 knockdown differentially modulates pro-inflammatory cytokines in BDSO-treated conditions, indicating strain-dependent effects and Cx50-mediated neuron-astrocyte crosstalk"
14. ID: 42439282 - Application: LPS effects on astrocyte cell lines. - "LPS reduced cell viability in a concentration-dependent manner in both AWT and MG6 cells, inducing apoptotic cell death in AWT cells"
15. ID: 42599550 - Application: Astrocyte reactive state in PD. - "Activated astrocytes accelerate neuronal degeneration by releasing inflammatory mediators, disrupting glutamate homeostasis, and triggering oxidative stress."
16. ID: 42456384 - Application: Tweak/Snhg3 feedback loop. - "Tweak and Snhg3 mutually upregulated each other and synergistically activated the Stat1 pathway, forming a positive feedback loop in MAs that collectively drived astrocyte activation."
17. ID: 42425228 - Application: Local translation in PAPs. - "Mechanistically, early Serpina3n upregulation was partially driven by JAK-STAT3 signaling, with preferential effects in astrocyte processes."
18. ID: 42365203 - Application: Distinct glial phenotypes. - "However, there is growing evidence that human and mouse glia adopt distinct phenotypes in response to neurodegeneration."
19. ID: 42502884 - Application: Piezo1 regulation. - "Microglial depletion in 5xFAD mice consistently and substantially reduced astrocytic Piezo1 expression in vivo, supporting the physiological relevance of this microglia-astrocyte signaling axis during pathology."
20. ID: 42557483 - Application: circRNAs in PD. - "Recent research has indicated that circRNAs participate in PD pathophysiology by modulating neuroinflammation, immune response, mitochondrial dysfunction, and reactive oxygen species accumulation."



### Perspective R2: Claim [Run2 Eval1 Synthesis] evaluated against Evidence [N/A]
- Alignment Score: 5/7
- Consilience Score: 6/7
- Directional Logic: High Score = SUPPORTS Original Claim
Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.

###[CLAIM EVALUATED AND ANSWER TO USER]
"Neuroinflammatory astrocyte subtypes in the mouse brain"

### [ABSTRACT & REWRITTEN CLAIM]
Neuroinflammatory astrocyte subtypes are defined by heterogeneous transcriptional states that modulate central nervous system (CNS) homeostasis, blood-brain barrier (BBB) integrity, and neuronal repair. Research identifies specific reactive astrocyte subpopulations (e.g., Osmr+ astrocytes) that emerge following traumatic injury, exhibiting distinct metabolic and inflammatory gene signatures. These astrocytes function as critical nodes in orchestrating neuroimmune responses through the release of cytokines, interactions with microglia, and regulation of the glymphatic system.

### [INTRODUCTION & JUSTIFICATION]
Astrocytes are no longer viewed merely as structural support cells; they are highly diversified, homeostatic regulators of the CNS. Recent transcriptomic evidence, particularly in mouse models of injury and neurodegeneration, has mapped distinct reactive profiles. A landmark reanalysis of single-cell RNA-sequencing data identified that "We identified five astrocyte subpopulations." Among these, "Descriptive analysis of the pooled cells showed a greater relative proportion of C3 Osmr+ astrocytes in the TBI group than in the Sham group." This specific subtype exhibits a "highly reactive transcriptional state with concurrent protection-associated and neurotoxicity-associated features." 

The reactivity of astrocytes is context-dependent. While they can be neuroprotective, "Persistent biomechanical and ischemic insults shift this profile into a typically deleterious one." In the context of inflammatory responses, "These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways." This capacity extends to the regulation of innate immunity, as "Astrocytic TRPC6 maintains BBB integrity by negatively regulating the cGAS-STING innate immune pathway in the early phase of CIRI." The functional consequences of these inflammatory states are profound: "Mechanistically, DNA synergized with pro-inflammatory cytokines to trigger astrocytic STING signaling, driving Clusterin (CLU) secretion that directly induced oligodendrocyte apoptosis and demyelination."

### [DISCUSSION: NOVEL & OVERLOOKED]
*   **Transcriptional Heterogeneity:** Astrocytes exist in at least five distinct subpopulations following traumatic injury, with Osmr+ variants exhibiting specific neurotoxic and protective metabolic signatures.
*   **Mechanical Sensing:** Endothelial Piezo1 sensors translate mechanical stress into astrocytic apoptosis via cAMP-Epac1 microvesicular signaling.
*   **Gut-Brain Signaling:** Chronic enteric gliosis in Parkinson's disease-model mice (A53T) precedes CNS inflammation, driven by LRRK2 up-regulation.
*   **Barrier Regulation:** Astrocytes serve as primary regulators of the blood-brain barrier, often utilizing the cGAS-STING pathway to govern tight junction stability.
*   **Regenerative Potential:** "Direct in situ astrocyte-to-neuron reprogramming offers a compelling regenerative alternative by leveraging the abundant endogenous glial reservoir," though this is hindered by existing epigenetic memory.
*   **Stress Resilience:** Structural depolymerization of AQP4 orthogonal array particles in A25Q mutant mice confers resilience to chronic stress by dampening glial-mediated neuroinflammation.
*   **Developmental Plasticity:** Adolescent intermittent ethanol exposure disrupts the physical and functional coupling of astrocytes to synapses, a deficit that persists into adulthood.
*   **Metabolic Rewiring:** Astrocytes undergo significant metabolic transitions during reprogramming, shifting from glycolysis to oxidative phosphorylation to support nascent neuronal survival.

### [EVIDENCE, METHODOLOGY & CITATIONS]
1. ID: 42603599 - "We identified five astrocyte subpopulations. Descriptive analysis of the pooled cells showed a greater relative proportion of C3 Osmr+ astrocytes in the TBI group than in the Sham group."
2. ID: 42603599 - "This subpopulation exhibited a highly reactive transcriptional state with concurrent protection-associated and neurotoxicity-associated features"
3. ID: 42604981 - "Astrocytes are fundamental elements of the pathophysiology of neurological, neuropsychiatric, and neurodegenerative diseases"
4. ID: 42589548 - "Initially, the macroglial response is adaptive and neuroprotective. Persistent biomechanical and ischemic insults shift this profile into a typically deleterious one"
5. ID: 42586471 - "Astrocytic TRPC6 maintains BBB integrity by negatively regulating the cGAS-STING innate immune pathway in the early phase of CIRI."
6. ID: 42601829 - "Mechanistically, DNA synergized with pro-inflammatory cytokines to trigger astrocytic STING signaling, driving Clusterin (CLU) secretion that directly induced oligodendrocyte apoptosis and demyelination."
7. ID: 42576543 - "The vesicular cAMP payload subsequently activated the downstream effector Epac1, dictating a spatially restricted wave of astrocyte apoptosis."
8. ID: 42593416 - "A53T mice, without central neuroinflammation, showed intestinal disturbances, colonic α-synuclein accumulation and an increase in colonic GFAP+/LRRK2+ glial cells before brain pathology."
9. ID: 42574907 - "In ICH, cGAS-STING activation in microglia and astrocytes drives neuroinflammation, promotes pyroptosis via inflammasome assembly, disrupts blood-brain barrier (BBB) integrity, and exacerbates secondary brain injury."
10. ID: 42604624 - "genetic knockdown as well as inhibition of NQO2 in astrocytes promote neurite regrowth of injured cortical neurons."
11. ID: 42576592 - "The role of the Purinergic receptor (P2X7 receptor), a ligand-gated ion channel activated by extracellular ATP, was examined across existing cellular mechanisms and possible pathways involved in AD"
12. ID: 42579790 - "Direct intrathecal IL-6 blockade was associated with qualitative cellular-level neuroprotection after permanent focal cerebral ischemia."
13. ID: 42573852 - "Direct in situ astrocyte-to-neuron reprogramming offers a compelling regenerative alternative by leveraging the abundant endogenous glial reservoir."
14. ID: 42595228 - "CUMS induced marked astrocytic (GFAP, S100β) and microglial (Iba-1, CD68) activation in WT hippocampus, but these responses were largely absent in mutants."
15. ID: 42603821 - "AIE induces structural and functional decoupling of astrocytes from synapses and astrocyte dysregulation that persists into adulthood."
16. ID: 42568651 - "After SCI, autonomic dysfunction, impaired gut motility, and neurogenic bowel dysfunction may disrupt the homeostasis of gut microbiota and barrier"
17. ID: 42591297 - "These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways."
18. ID: 42600992 - "Intranasal rhInsulin treatment significantly attenuated HI-induced behavioral deficits by 100% and increased myelination (MBP+) by 64% in cingulate white matter, restored dendritic expression (MAP2+) by 56%, and reduced astrocytes (GFAP+) by 70% in hippocampal regions"
19. ID: 42574907 - "In SAH, the pathway is engaged through cytosolic mtDNA release and transcellular cGAMP transfer from neurons to microglia, amplifying neuroinflammation, ferroptosis, NLRP3 inflammasome activation, and autophagic dysfunction."
20. ID: 42576543 - "Although Piezo1 was broadly detected in glial cells, genetic ablation of Piezo1 exclusively in endothelial cells, but not in astrocytes or microglia, significantly reduced infarct volume and improved neurological deficits."



### Perspective R3: Claim [Run3 Eval1 Synthesis] evaluated against Evidence [N/A]
- Alignment Score: 7/7
- Consilience Score: 6/7
- Directional Logic: High Score = SUPPORTS Original Claim
Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.

###[CLAIM EVALUATED AND ANSWER TO USER]
Neuroinflammatory astrocyte subtypes in the mouse brain

### [ABSTRACT & REWRITTEN CLAIM]
This assessment evaluates the evidence regarding distinct neuroinflammatory astrocyte subtypes (often termed A1/A2-like or disease-associated) within the murine central nervous system. The literature identifies that astrocytes undergo profound transcriptional and morphological reprogramming under pathological conditions, such as traumatic brain injury (TBI), ischemia, and neurodegeneration. These subtypes are characterized by specific molecular markers and signaling axes that either promote tissue damage or facilitate repair, though recent data emphasize that these classical binary labels (A1/A2) are simplified representations of a complex, heterogeneous cellular state.

### [INTRODUCTION & JUSTIFICATION]
Astrocytes are no longer viewed merely as passive support cells; they are dynamic participants in CNS pathology, capable of adopting distinct transcriptional states in response to injury. "These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways." This immune competence is further refined through specific genetic pathways. "The study identified the "Astrocyte TRPC6-STING-Tight Junction" axis, offering a precise and promising novel therapeutic target for CIRI." Under aging or injury, these cells demonstrate marked morphological remodeling. "Data show that brain aging alters the tridimensional structure of microglia and astrocytes in the hippocampus and prefrontal cortex." Furthermore, the "A1/A2" paradigm, while historically used to categorize reactive states, is now recognized as insufficient to capture the full diversity of these responses, particularly when interventions like electroacupuncture modulate them. "EA at GV20 and GV24 improves cognitive impairment and attenuate neuroinflammation in VD rats possibly by inhibiting TLR4/MyD88/NF-κB signaling and regulating astrocytic A1/A2-like phenotypic imbalance."

### [DISCUSSION: NOVEL & OVERLOOKED]
*   Astrocyte reactivity is not merely a binary 'A1/A2' state; modern transcriptomic analysis reveals finer gradations of cellular activation.
*   The TRPC6-STING pathway represents a specific, druggable hub for stabilizing the blood-brain barrier via astrocytes during ischemia.
*   Peripheral inflammation, as seen in atopic dermatitis or respiratory infection, directly reshapes cortical astrocytic transcriptional landscapes.
*   Senescence markers in astrocytes and neurons represent a distinct, aging-associated inflammatory pathway mediated by cGAS-STING.
*   Dietary interventions, such as a nut-enriched diet, can actively suppress pro-inflammatory astrocyte markers in AD mouse models.
*   Clusterin (CLU) secretion from astrocytes, triggered by STING activation, is a primary driver of oligodendrocyte apoptosis in MS.
*   FGF13 acts as a critical molecular switch that prevents astrocytic apoptosis and associated depression-like behavioral deficits.
*   The Tweak/Fn14 and Stat1 signaling loop constitutes a positive feedback mechanism specifically fueling astrocytic activation in TLE.

### [EVIDENCE, METHODOLOGY & CITATIONS]
1. ID: 42591297 - These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways.
2. ID: 42586471 - The study identified the "Astrocyte TRPC6-STING-Tight Junction" axis, offering a precise and promising novel therapeutic target for CIRI.
3. ID: 42582005 - In contrast, PE more consistently reverses age-related microglial gene expression changes and induces region-specific remodeling of astrocytic morphology.
4. ID: 42576490 - EA at GV20 and GV24 improves cognitive impairment and attenuate neuroinflammation in VD rats possibly by inhibiting TLR4/MyD88/NF-κB signaling and regulating astrocytic A1/A2-like phenotypic imbalance.
5. ID: 42547491 - Studies suggest that in schizophrenia, inflammatory changes may influence brain cells, chemical signals, stress pathways, and the systems involved in sensing and responding to pain.
6. ID: 42462474 - Our findings identify a novel circSLC8A1/PTBP1/CEBPB signaling axis that mediates astrocytic inflammation and pyroptosis in TLE.
7. ID: 42444329 - These findings support a role for C1q in astrocytic C3 induction and the engulfment of both synapses and amyloid.
8. ID: 42438359 - Data show that brain aging alters the tridimensional structure of microglia and astrocytes in the hippocampus and prefrontal cortex.
9. ID: 42421017 - Astrocyte-specific knockout of FGF13 induces astrocytic apoptosis, exacerbates inflammatory levels, and aggravates depression-like behaviors in mice.
10. ID: 42418159 - In APP mice, NED enhanced hippocampal-dependent memory, reduced microglia and astrocyte reactivity, decreased cortical and hippocampal Aβ plaque burden, and preserved dendritic spine density.
11. ID: 42401926 - In addition, elevated expression of β-galactosidase, a senescence marker, was predominantly observed in neurons compared to microglia and astrocytes, indicating a primary role for neurons in infection-associated senescence.
12. ID: 42446255 - In the control, microglial cells possessed a large number of processes typical of nonactivated cells.
13. ID: 42599550 - Recent studies indicate that mutations in PD-associated genes may induce functional alterations in astrocytes.
14. ID: 42575454 - The ipsilateral hippocampus exhibited early blood-brain barrier (BBB) disruption and astrocytic alterations, whereas the contralateral hippocampus developed a more pronounced and sustained inflammatory response characterized by microglial activation and increased expression of inflammatory and endothelial activation markers.
15. ID: 42567990 - TBI significantly and temporarily increased the expression of PDCD1 in vivo, with PDCD1 mostly expressed in microglia and neurons, but not in astrocytes.
16. ID: 42552556 - However, a significant increase in Galectin-3/GFAP colocalization compared to control at the same timepoint in the rat additionally associates Galectin-3 production with astrocytes and Müller glia.
17. ID: 42557563 - Spatial transcriptomics revealed that CXCL10 is mainly expressed by disease-associated astrocytes, defining an astrocytic CXCL10-rich inflammatory niche within the tauopathy brain.
18. ID: 42456384 - Conversely, up-regulation of Tweak or Snhg3 promoted proliferation, migration, and inflammatory factor secretion in mouse astrocytes (MAs), indicating that TWEAK and Snhg3 each induce glial activation in vitro.
19. ID: 42484902 - We demonstrated morphological alterations of BAM populations in the meninges and parallel disintegration of the astrocyte barrier due to haemorrhage.
20. ID: 42427668 - E4FAD mice demonstrated plaque reductions with accompanying increases in microhemorrhages (measured on both MRI and histology), and increases in microglial and astrocyte reactivity - especially in the perivascular compartment.



## Logical Systems Map (Logical Gates)
- "Pathologic Processes" -> "Gene Expression Regulation"
- "Gene Expression Regulation" -> "Biological Phenomena"
- "Biological Phenomena" -> "Neuroinflammatory Diseases"
- "Traumatic Injury" -> "Astrocytes"
- "Reactive Astrocytes" -> "Blood-Brain Barrier"
- "Astrocytes" -> "Brain Injuries"
- "Pathologic Processes" -> "Membrane Proteins"
- "Membrane Proteins" -> "Astrocytes"

## Verified Verbatim Quotes
- "LMP2 coordinately modulates inflammatory and reparative signaling networks by promoting nuclear factor kappa-B (NF-κB)-dependent inflammatory activation while constraining transforming growth factor-β1(TGF-β1)/SMAD family member 3 (Smad3)-associated reparative responses"
- "exosome function is highly state-dependent and cannot be fully explained by simplified pro-inflammatory microglia anti-inflammatory microglia (M1/M2) or A1/A2 paradigms"
- "MINK1 and PLEKHB1 showed preferential expression in hippocampal and cortical astrocytes, respectively, highlighting their potential as region-specific astrocyte markers."
- "Exogenous LPI treatment reduced cerebral Aβ deposition, improved performance in learning and memory behavioral tasks, reduced pathological microglial aggregation, inhibited astrocyte proliferation, and ameliorated hippocampal oxidative stress."
- "Integrated epigenomic, proteomic, and metabolomic profiling of cortical astrocytes isolated 28 days after injury revealed a pronounced metabolic restriction in wild type astrocytes"
- "While the brain relies on lactate as a prominent energy substrate, astrocytic metabolic defects lead to impaired neuronal energy homeostasis, thereby promoting neurodegeneration."
- "The resulting cell line recapitulates key pathological features, including lysosomal accumulation, increased neutral lipid content, reduced mitochondrial mass, and elevated reactive oxygen species production."
- "circSLC8A1 was significantly upregulated in the hippocampus of TLE mice and predominantly localized in astrocytes."
- "Mild hyperthermia upregulated P2X7 expression in astrocytes and induced a substantial calcium influx, leading to activation of the Calcineurin-NFAT pathway."
- "Aquaporin 4 (AQP4) water channels are polarized to astrocytic endfeet at blood vessel interfaces, and lose polarity in vascular diseases"
- "The treatment induced a spatial and phenotypic restructuring of the astrocytic response, notably reducing excessive astrocyte accumulation around lesions while encouraging a proliferative and reparative phenotype."
- "EHMT1+/- astrocytes displayed elevated levels of S100B, a neuroinflammatory marker contributing to neuronal network hyperactivity."
- "Cx50 knockdown differentially modulates pro-inflammatory cytokines in BDSO-treated conditions, indicating strain-dependent effects and Cx50-mediated neuron-astrocyte crosstalk"
- "LPS reduced cell viability in a concentration-dependent manner in both AWT and MG6 cells, inducing apoptotic cell death in AWT cells"
- "Activated astrocytes accelerate neuronal degeneration by releasing inflammatory mediators, disrupting glutamate homeostasis, and triggering oxidative stress."
- "Tweak and Snhg3 mutually upregulated each other and synergistically activated the Stat1 pathway, forming a positive feedback loop in MAs that collectively drived astrocyte activation."
- "LMP2 coordinately modulates inflammatory and reparative signaling networks by promoting nuclear factor kappa-B (NF-κB)-dependent inflammatory activation while constraining transforming growth factor-β1(TGF-β1)/SMAD family member 3 (Smad3)-associated reparative responses"
- "exosome function is highly state-dependent and cannot be fully explained by simplified pro-inflammatory microglia anti-inflammatory microglia (M1/M2) or A1/A2 paradigms"
- "MINK1 and PLEKHB1 showed preferential expression in hippocampal and cortical astrocytes, respectively, highlighting their potential as region-specific astrocyte markers."
- "Exogenous LPI treatment reduced cerebral Aβ deposition, improved performance in learning and memory behavioral tasks, reduced pathological microglial aggregation, inhibited astrocyte proliferation, and ameliorated hippocampal oxidative stress."
- "Integrated epigenomic, proteomic, and metabolomic profiling of cortical astrocytes isolated 28 days after injury revealed a pronounced metabolic restriction in wild type astrocytes"
- "While the brain relies on lactate as a prominent energy substrate, astrocytic metabolic defects lead to impaired neuronal energy homeostasis, thereby promoting neurodegeneration."
- "The resulting cell line recapitulates key pathological features, including lysosomal accumulation, increased neutral lipid content, reduced mitochondrial mass, and elevated reactive oxygen species production."
- "circSLC8A1 was significantly upregulated in the hippocampus of TLE mice and predominantly localized in astrocytes."
- "Mild hyperthermia upregulated P2X7 expression in astrocytes and induced a substantial calcium influx, leading to activation of the Calcineurin-NFAT pathway."
- "Aquaporin 4 (AQP4) water channels are polarized to astrocytic endfeet at blood vessel interfaces, and lose polarity in vascular diseases"
- "The treatment induced a spatial and phenotypic restructuring of the astrocytic response, notably reducing excessive astrocyte accumulation around lesions while encouraging a proliferative and reparative phenotype."
- "EHMT1+/- astrocytes displayed elevated levels of S100B, a neuroinflammatory marker contributing to neuronal network hyperactivity."
- "Cx50 knockdown differentially modulates pro-inflammatory cytokines in BDSO-treated conditions, indicating strain-dependent effects and Cx50-mediated neuron-astrocyte crosstalk"
- "LPS reduced cell viability in a concentration-dependent manner in both AWT and MG6 cells, inducing apoptotic cell death in AWT cells"
- "Activated astrocytes accelerate neuronal degeneration by releasing inflammatory mediators, disrupting glutamate homeostasis, and triggering oxidative stress."
- "Tweak and Snhg3 mutually upregulated each other and synergistically activated the Stat1 pathway, forming a positive feedback loop in MAs that collectively drived astrocyte activation."
- "Mechanistically, early Serpina3n upregulation was partially driven by JAK-STAT3 signaling, with preferential effects in astrocyte processes."
- "However, there is growing evidence that human and mouse glia adopt distinct phenotypes in response to neurodegeneration."
- "Microglial depletion in 5xFAD mice consistently and substantially reduced astrocytic Piezo1 expression in vivo, supporting the physiological relevance of this microglia-astrocyte signaling axis during pathology."
- "Recent research has indicated that circRNAs participate in PD pathophysiology by modulating neuroinflammation, immune response, mitochondrial dysfunction, and reactive oxygen species accumulation."
- "We identified five astrocyte subpopulations. Descriptive analysis of the pooled cells showed a greater relative proportion of C3 Osmr+ astrocytes in the TBI group than in the Sham group."
- "This subpopulation exhibited a highly reactive transcriptional state with concurrent protection-associated and neurotoxicity-associated features"
- "Astrocytes are fundamental elements of the pathophysiology of neurological, neuropsychiatric, and neurodegenerative diseases"
- "Initially, the macroglial response is adaptive and neuroprotective. Persistent biomechanical and ischemic insults shift this profile into a typically deleterious one"
- "Astrocytic TRPC6 maintains BBB integrity by negatively regulating the cGAS-STING innate immune pathway in the early phase of CIRI."
- "Mechanistically, DNA synergized with pro-inflammatory cytokines to trigger astrocytic STING signaling, driving Clusterin (CLU) secretion that directly induced oligodendrocyte apoptosis and demyelination."
- "The vesicular cAMP payload subsequently activated the downstream effector Epac1, dictating a spatially restricted wave of astrocyte apoptosis."
- "A53T mice, without central neuroinflammation, showed intestinal disturbances, colonic α-synuclein accumulation and an increase in colonic GFAP+/LRRK2+ glial cells before brain pathology."
- "In ICH, cGAS-STING activation in microglia and astrocytes drives neuroinflammation, promotes pyroptosis via inflammasome assembly, disrupts blood-brain barrier (BBB) integrity, and exacerbates secondary brain injury."
- "genetic knockdown as well as inhibition of NQO2 in astrocytes promote neurite regrowth of injured cortical neurons."
- "The role of the Purinergic receptor (P2X7 receptor), a ligand-gated ion channel activated by extracellular ATP, was examined across existing cellular mechanisms and possible pathways involved in AD"
- "Direct intrathecal IL-6 blockade was associated with qualitative cellular-level neuroprotection after permanent focal cerebral ischemia."
- "Direct in situ astrocyte-to-neuron reprogramming offers a compelling regenerative alternative by leveraging the abundant endogenous glial reservoir."
- "CUMS induced marked astrocytic (GFAP, S100β) and microglial (Iba-1, CD68) activation in WT hippocampus, but these responses were largely absent in mutants."
- "AIE induces structural and functional decoupling of astrocytes from synapses and astrocyte dysregulation that persists into adulthood."
- "After SCI, autonomic dysfunction, impaired gut motility, and neurogenic bowel dysfunction may disrupt the homeostasis of gut microbiota and barrier"
- "These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways."
- "Intranasal rhInsulin treatment significantly attenuated HI-induced behavioral deficits by 100% and increased myelination (MBP+) by 64% in cingulate white matter, restored dendritic expression (MAP2+) by 56%, and reduced astrocytes (GFAP+) by 70% in hippocampal regions"
- "In SAH, the pathway is engaged through cytosolic mtDNA release and transcellular cGAMP transfer from neurons to microglia, amplifying neuroinflammation, ferroptosis, NLRP3 inflammasome activation, and autophagic dysfunction."
- "We identified five astrocyte subpopulations. Descriptive analysis of the pooled cells showed a greater relative proportion of C3 Osmr+ astrocytes in the TBI group than in the Sham group."
- "This subpopulation exhibited a highly reactive transcriptional state with concurrent protection-associated and neurotoxicity-associated features"
- "Astrocytes are fundamental elements of the pathophysiology of neurological, neuropsychiatric, and neurodegenerative diseases"
- "Initially, the macroglial response is adaptive and neuroprotective. Persistent biomechanical and ischemic insults shift this profile into a typically deleterious one"
- "Astrocytic TRPC6 maintains BBB integrity by negatively regulating the cGAS-STING innate immune pathway in the early phase of CIRI."
- "Mechanistically, DNA synergized with pro-inflammatory cytokines to trigger astrocytic STING signaling, driving Clusterin (CLU) secretion that directly induced oligodendrocyte apoptosis and demyelination."
- "The vesicular cAMP payload subsequently activated the downstream effector Epac1, dictating a spatially restricted wave of astrocyte apoptosis."
- "A53T mice, without central neuroinflammation, showed intestinal disturbances, colonic α-synuclein accumulation and an increase in colonic GFAP+/LRRK2+ glial cells before brain pathology."
- "In ICH, cGAS-STING activation in microglia and astrocytes drives neuroinflammation, promotes pyroptosis via inflammasome assembly, disrupts blood-brain barrier (BBB) integrity, and exacerbates secondary brain injury."
- "genetic knockdown as well as inhibition of NQO2 in astrocytes promote neurite regrowth of injured cortical neurons."
- "The role of the Purinergic receptor (P2X7 receptor), a ligand-gated ion channel activated by extracellular ATP, was examined across existing cellular mechanisms and possible pathways involved in AD"
- "Direct intrathecal IL-6 blockade was associated with qualitative cellular-level neuroprotection after permanent focal cerebral ischemia."
- "Direct in situ astrocyte-to-neuron reprogramming offers a compelling regenerative alternative by leveraging the abundant endogenous glial reservoir."
- "CUMS induced marked astrocytic (GFAP, S100β) and microglial (Iba-1, CD68) activation in WT hippocampus, but these responses were largely absent in mutants."
- "AIE induces structural and functional decoupling of astrocytes from synapses and astrocyte dysregulation that persists into adulthood."
- "After SCI, autonomic dysfunction, impaired gut motility, and neurogenic bowel dysfunction may disrupt the homeostasis of gut microbiota and barrier"
- "These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways."
- "Intranasal rhInsulin treatment significantly attenuated HI-induced behavioral deficits by 100% and increased myelination (MBP+) by 64% in cingulate white matter, restored dendritic expression (MAP2+) by 56%, and reduced astrocytes (GFAP+) by 70% in hippocampal regions"
- "In SAH, the pathway is engaged through cytosolic mtDNA release and transcellular cGAMP transfer from neurons to microglia, amplifying neuroinflammation, ferroptosis, NLRP3 inflammasome activation, and autophagic dysfunction."
- "Although Piezo1 was broadly detected in glial cells, genetic ablation of Piezo1 exclusively in endothelial cells, but not in astrocytes or microglia, significantly reduced infarct volume and improved neurological deficits."
- "These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways."
- "The study identified the "Astrocyte TRPC6-STING-Tight Junction" axis, offering a precise and promising novel therapeutic target for CIRI."
- "In contrast, PE more consistently reverses age-related microglial gene expression changes and induces region-specific remodeling of astrocytic morphology."
- "EA at GV20 and GV24 improves cognitive impairment and attenuate neuroinflammation in VD rats possibly by inhibiting TLR4/MyD88/NF-κB signaling and regulating astrocytic A1/A2-like phenotypic imbalance."
- "Studies suggest that in schizophrenia, inflammatory changes may influence brain cells, chemical signals, stress pathways, and the systems involved in sensing and responding to pain."
- "Our findings identify a novel circSLC8A1/PTBP1/CEBPB signaling axis that mediates astrocytic inflammation and pyroptosis in TLE."
- "These findings support a role for C1q in astrocytic C3 induction and the engulfment of both synapses and amyloid."
- "Data show that brain aging alters the tridimensional structure of microglia and astrocytes in the hippocampus and prefrontal cortex."
- "Astrocyte-specific knockout of FGF13 induces astrocytic apoptosis, exacerbates inflammatory levels, and aggravates depression-like behaviors in mice."
- "In APP mice, NED enhanced hippocampal-dependent memory, reduced microglia and astrocyte reactivity, decreased cortical and hippocampal Aβ plaque burden, and preserved dendritic spine density."
- "In addition, elevated expression of β-galactosidase, a senescence marker, was predominantly observed in neurons compared to microglia and astrocytes, indicating a primary role for neurons in infection-associated senescence."
- "These findings emphasize the ability of astrocytes to act as immunocompetent cells that coordinate inflammatory responses through mechanisms such as the NOD-like receptor and NF-κB pathways."
- "The study identified the "Astrocyte TRPC6-STING-Tight Junction" axis, offering a precise and promising novel therapeutic target for CIRI."
- "In contrast, PE more consistently reverses age-related microglial gene expression changes and induces region-specific remodeling of astrocytic morphology."
- "EA at GV20 and GV24 improves cognitive impairment and attenuate neuroinflammation in VD rats possibly by inhibiting TLR4/MyD88/NF-κB signaling and regulating astrocytic A1/A2-like phenotypic imbalance."
- "Studies suggest that in schizophrenia, inflammatory changes may influence brain cells, chemical signals, stress pathways, and the systems involved in sensing and responding to pain."
- "Our findings identify a novel circSLC8A1/PTBP1/CEBPB signaling axis that mediates astrocytic inflammation and pyroptosis in TLE."
- "These findings support a role for C1q in astrocytic C3 induction and the engulfment of both synapses and amyloid."
- "Data show that brain aging alters the tridimensional structure of microglia and astrocytes in the hippocampus and prefrontal cortex."
- "Astrocyte-specific knockout of FGF13 induces astrocytic apoptosis, exacerbates inflammatory levels, and aggravates depression-like behaviors in mice."
- "In APP mice, NED enhanced hippocampal-dependent memory, reduced microglia and astrocyte reactivity, decreased cortical and hippocampal Aβ plaque burden, and preserved dendritic spine density."
- "In addition, elevated expression of β-galactosidase, a senescence marker, was predominantly observed in neurons compared to microglia and astrocytes, indicating a primary role for neurons in infection-associated senescence."
- "In the control, microglial cells possessed a large number of processes typical of nonactivated cells."
- "Recent studies indicate that mutations in PD-associated genes may induce functional alterations in astrocytes."
- "The ipsilateral hippocampus exhibited early blood-brain barrier (BBB) disruption and astrocytic alterations, whereas the contralateral hippocampus developed a more pronounced and sustained inflammatory response characterized by microglial activation and increased expression of inflammatory and endothelial activation markers."
- "TBI significantly and temporarily increased the expression of PDCD1 in vivo, with PDCD1 mostly expressed in microglia and neurons, but not in astrocytes."
- "However, a significant increase in Galectin-3/GFAP colocalization compared to control at the same timepoint in the rat additionally associates Galectin-3 production with astrocytes and Müller glia."
- "Spatial transcriptomics revealed that CXCL10 is mainly expressed by disease-associated astrocytes, defining an astrocytic CXCL10-rich inflammatory niche within the tauopathy brain."
- "Conversely, up-regulation of Tweak or Snhg3 promoted proliferation, migration, and inflammatory factor secretion in mouse astrocytes (MAs), indicating that TWEAK and Snhg3 each induce glial activation in vitro."
- "We demonstrated morphological alterations of BAM populations in the meninges and parallel disintegration of the astrocyte barrier due to haemorrhage."
- "E4FAD mice demonstrated plaque reductions with accompanying increases in microhemorrhages (measured on both MRI and histology), and increases in microglial and astrocyte reactivity - especially in the perivascular compartment."